Lipocine Inc (NASDAQ:LPCN) Stock Jumped 8% Last Week After The FDA News

November 6, 2021

Shares of Lipocine Inc (NASDAQ:LPCN) closed higher last week after releasing key FDA updates. Trading Data On Friday, LPCN stock moved down 5.08% at $1.1200 with more than 775.21K shares, compared to its average volume of 878.01K shares. The stock has moved within a range of $1.0900 – 1.1800 after opening the trade at $1.1800. FDA Grants Fast Track Designation to LPCN 1144 for Treatment of Non-Cirrhotic NASH Clinical-stage biopharmaceutical…


Lipocine Inc (NASDAQ:LPCN) Stock Attempts To Recover: Now What?

August 8, 2021

This past week the biopharmaceutical company Lipocine Inc (NASDAQ:LPCN) was in focus among investors after it announced its financial results for the second fiscal quarter of 2021 that ended on June 30. The financial results were announced this past Thursday but it was yesterday that the Lipocine stock moved and went up by 3%. In this situation, it could be a good idea for investors to take a closer look…